Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Skin Irritation

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    81 result(s) found for: Skin Irritation. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2009-013275-21 Sponsor Protocol Number: 05-2009 Start Date*: 2009-12-03
    Sponsor Name:Imperial College Healthcare NHS Trust
    Full Title: Pilot Study: Evaluating the effect of 300microgram testosterone patches in addition to Hormone Replacement Therapy on arterial compliance, insulin resistance and sexual desire
    Medical condition: Arterial compliance Insulin sensitivity Decreased sexual desire after menopause
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020112 Hirsutism LLT
    9.1 10001763 Alopecia, reversible LLT
    9.1 10000496 Acne LLT
    9.1 10059294 Oily skin LLT
    9.1 10028813 Nausea LLT
    9.1 10040880 Skin irritation LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-005911-25 Sponsor Protocol Number: 001 Start Date*: 2008-10-10
    Sponsor Name:Imperial College Healthcare NHS Trust
    Full Title: A randomised, placebo controlled, double blind study to evaluate the effect of 300mcg testosterone patches in addition to HRT on arterial compliance, insulin resistance and sexual desire.
    Medical condition: - arterial compliance - insulin resistance - decreased sexual desire after menopause
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020112 Hirsutism LLT
    9.1 10001763 Alopecia reversible LLT
    9.1 10000496 Acne LLT
    9.1 10059294 Oily skin LLT
    9.1 10028813 Nausea LLT
    9.1 10040880 Skin irritation LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2004-004466-33 Sponsor Protocol Number: DCC 04 AM 012 Start Date*: 2005-08-01
    Sponsor Name:Dr. Theiss Naturwaren GmbH
    Full Title: doubleblind (observer blind), placebo-controlled, clinical-experimental study phase II in order to examine the local compatibility of Dr. Theiss Ringelblumen Salbe N by the duhring-chamber-test and...
    Medical condition: healthy subjects with normal skin conditions
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004511-39 Sponsor Protocol Number: DCC04AM005 Start Date*: 2005-04-29
    Sponsor Name:Dr. Theiss Naturwaren GmbH
    Full Title: Double blind (observer Blind) Placebo controlled, clinical-experimental Study of the Phase II for the examination of the local tolerance by Duhring-Chamber-Test as well as open user trial of the pr...
    Medical condition: healthy subjects with normal skin conditions
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004829-97 Sponsor Protocol Number: S241-GB-01 Start Date*: 2005-01-05
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D)
    Full Title: 96 HOUR HUMAN PATCH TEST FOR ASSESSMENT OF PRIMARY SKIN IRRITATION
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000552-27 Sponsor Protocol Number: ACO2008-CT-01 Start Date*: 2008-06-11
    Sponsor Name:ACO HUD NORDIC AB
    Full Title: Effect of moisturizing creams on skin barrier function and prevention of Malassezia recurrence in patients with atopic eczema
    Medical condition: Dry skin barrier disorders such as atopic eczema and ichtyosis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000704-14 Sponsor Protocol Number: S241-GB-07 Start Date*: Information not available in EudraCT
    Sponsor Name:Stiefel Laboratories International Division
    Full Title: Human 96 Hour Repeat Open Application Test for Assessment of Skin Irritation
    Medical condition: Not applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2016-004635-20 Sponsor Protocol Number: P1605NY Start Date*: 2017-03-24
    Sponsor Name:G. Pohl-Boskamp GmbH & Co. KG
    Full Title: A monocentric, randomized, controlled, investigator-blind trial to evaluate the efficacy and safety of an investigational medical device (PB790) in subjects with head lice.
    Medical condition: Headlice infestation
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10019197 Head lice LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004830-15 Sponsor Protocol Number: S241-GB-02 Start Date*: 2005-01-31
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D)
    Full Title: Human Repeat Insult Patch Test with Challenge
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005897-54 Sponsor Protocol Number: S241-GB-08 Start Date*: 2006-02-01
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd
    Full Title: A Phase 1, Single-Centre, Single-blind, CPO Solution Human Patch Test in Healthy Subjects
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005916-26 Sponsor Protocol Number: S241-GB-09 Start Date*: 2006-02-01
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd
    Full Title: A phase I, single-blind, CPO solution human repeat insult patch test in healthy subjects.
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-004870-78 Sponsor Protocol Number: 202100625 Start Date*: 2022-03-15
    Sponsor Name:University Medical Centre Groningen
    Full Title: Detecting mitochondrial oxygen tension (mitoPO2) as a measure of local tissue oxygenation in patients with various stages of PAD with the Cellular Oxygen Metabolism (COMET) measurement system of Ph...
    Medical condition: Peripheral Arterial disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-004662-26 Sponsor Protocol Number: LACAC_L_04298 Start Date*: 2015-03-25
    Sponsor Name:Sanofi
    Full Title: Safety Dermatological Evaluation: genital Mucosa Irritation - Product tested: Dermacyd PH_DETINLYN Sweet Flower.
    Medical condition: Healthy volunteers (hygiene)
    Disease: Version SOC Term Classification Code Term Level
    17.1 10042613 - Surgical and medical procedures 10053339 Routine health maintenance PT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-004664-38 Sponsor Protocol Number: LACAC_L_04304 Start Date*: 2015-03-25
    Sponsor Name:Sanofi
    Full Title: Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINLYN Tangerine Mix.
    Medical condition: Healthy volunteers (hygiene)
    Disease: Version SOC Term Classification Code Term Level
    17.1 10042613 - Surgical and medical procedures 10053339 Routine health maintenance PT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-004663-20 Sponsor Protocol Number: LACAC_L_04301 Start Date*: 2015-03-25
    Sponsor Name:Sanofi
    Full Title: Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINBACK Sweet Flower
    Medical condition: Healthy volunteers (hygiene)
    Disease: Version SOC Term Classification Code Term Level
    17.1 10042613 - Surgical and medical procedures 10053339 Routine health maintenance PT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-004665-24 Sponsor Protocol Number: LACAC_L_04307 Start Date*: 2015-03-25
    Sponsor Name:Sanofi
    Full Title: Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINBACK Tangerine Mix.
    Medical condition: Healthy volunteers (hygiene)
    Disease: Version SOC Term Classification Code Term Level
    17.1 10042613 - Surgical and medical procedures 10053339 Routine health maintenance PT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2019-001419-21 Sponsor Protocol Number: RC19_0042 Start Date*: 2019-09-16
    Sponsor Name:CHU de Nantes
    Full Title: Optimization of skin preparation to reduce Cutibacterium acnes colonization in superficial and deep samples during prosthetic shoulder surgery in male patients
    Medical condition: Cutibacterium acnes infection in shoulder arthroplasty with males
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-005649-12 Sponsor Protocol Number: SUCPAT1_CTR0026 Start Date*: 2006-12-20
    Sponsor Name:Regent Medical
    Full Title: A 96 hour (4-application) patch test and TEWL assessment in healthy volunteers to investigate the comparative skin irritation potential of six antiseptics and two controls following cutaneous patch...
    Medical condition: This trial will be carried out on healthy volunteers. Patches containing 0.2mls of each test product will be used. Each volunteer will have a single patch per product and the patches will be remov...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2004-002767-25 Sponsor Protocol Number: Calendula Studie Nr.1 Start Date*: 2005-03-21
    Sponsor Name:WALA Heilmittel GmbH
    Full Title: Clinical trial on the efficacy of Calendula-Echinacea Ointment in sodium lauryl sulphate irritation test. A monocentric, randomised, placebo-controlled double blind clinical trial.
    Medical condition: healthy male and female volunteers with artificial damage to the skin barrier and irritative contact dermatitis after application of sodium lauryl sulphate
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-002699-26 Sponsor Protocol Number: PREFECT Start Date*: 2015-10-08
    Sponsor Name:GWT-TUD GmbH
    Full Title: Pilot study of tolerability and effectivity following application of two combination topical acne products clindamycin 1% and 0.025% tretinoin gel (Acnatac® Gel), adapalen 0,1% and benzoyl peroxide...
    Medical condition: acne vulgaris
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 21:40:50 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA